Wilson Vallat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Wilson Vallat has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Aashray K. Gupta
University of Adelaide, Adelaide, Australia; Gold Coast University Hospital, Southport, Australia
1 shared publication - Alisha Moore
Trans Tasman Radiation Oncology Group (TROG Cancer Research) , Newcastle, New South Wales
1 shared publication - Amy Hsin-Chieh Hsieh
Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
1 shared publication Andrej Bece
Department of Radiation Oncology, St George Hospital , Sydney, New South Wales
1 shared publication- Andrew Mark Scott
Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Melbourne, Australia
1 shared publication - Andrew Pullar
Radiation Oncology Princess Alexandra Hospital Raymond Terrace (ROPART) Brisbane Queensland Australia
1 shared publication
Latest Publications
- Open Access
- 12 October 2026
- Published by S. Karger AG in Case Reports in Neurology
Posterior circulation stroke as the initial manifestation of giant cell arteritis: a case report
Background Giant cell arteritis (GCA) is a granulomatous vasculitis affecting medium and large arteries and is associated with severe complications including irreversible visual loss and aortic disease. Ischaemic stroke is an uncommon manifestation of GCA, but when present demonstrates a marked predilection for the vertebrobasilar circulation. Diagnosis may be challenging in the absence of classical cranial symptoms. Case Presentation A man in his 80s presented following an unwitnessed collapse and was found to have acute bilateral visual loss. CT brain and CT angiography demonstrated multifocal posterior circulation infarcts involving the bilateral occipital lobes and cerebellum with occlusion of the left posterior cerebral artery. MRI confirmed multifocal subacute infarction with haemorrhagic transformation. Initial investigations also identified a suspicious spiculated right upper lobe pulmonary lesion. FDG-PET performed for pulmonary malignancy evaluation demonstrated diffuse arterial uptake involving the brachiocephalic, carotid, subclavian, vertebral, and internal mammary arteries, raising suspicion for large-vessel vasculitis. Temporal artery biopsy subsequently confirmed GCA. The patient was commenced on high-dose corticosteroid therapy; however, bilateral functional blindness persisted, requiring discharge to residential aged care. Conclusion This case highlights an atypical presentation of GCA as multifocal posterior circulation stroke without preceding cranial or constitutional symptoms. Recognition of otherwise unexplained ischaemic stroke in conjunction with elevated inflammatory markers and large-vessel imaging abnormalities may facilitate earlier diagnosis and prompt initiation of immunosuppressive therapy in GCA-associated stroke.
- 12 October 2026
- Published by S. Karger AG in Case Reports in Neurology
Open AccessPosterior circulation stroke as the initial manifestation of giant cell arteritis: a case report
Background Giant cell arteritis (GCA) is a granulomatous vasculitis affecting medium and large arteries and is associated with severe complications including irreversible visual loss and aortic disease. Ischaemic stroke is an uncommon manifestation of GCA, but when present demonstrates a marked predilection for the vertebrobasilar circulation. Diagnosis may be challenging in the absence of classical cranial symptoms. Case Presentation A man in his 80s presented following an unwitnessed collapse and was found to have acute bilateral visual loss. CT brain and CT angiography demonstrated multifocal posterior circulation infarcts involving the bilateral occipital lobes and cerebellum with occlusion of the left posterior cerebral artery. MRI confirmed multifocal subacute infarction with haemorrhagic transformation. Initial investigations also identified a suspicious spiculated right upper lobe pulmonary lesion. FDG-PET performed for pulmonary malignancy evaluation demonstrated diffuse arterial uptake involving the brachiocephalic, carotid, subclavian, vertebral, and internal mammary arteries, raising suspicion for large-vessel vasculitis. Temporal artery biopsy subsequently confirmed GCA. The patient was commenced on high-dose corticosteroid therapy; however, bilateral functional blindness persisted, requiring discharge to residential aged care. Conclusion This case highlights an atypical presentation of GCA as multifocal posterior circulation stroke without preceding cranial or constitutional symptoms. Recognition of otherwise unexplained ischaemic stroke in conjunction with elevated inflammatory markers and large-vessel imaging abnormalities may facilitate earlier diagnosis and prompt initiation of immunosuppressive therapy in GCA-associated stroke.
- Open Access
- 24 September 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
Impact of [18F]FET-PET on MRI-based radiotherapy target volumes in newly diagnosed Glioblastoma: Results from the FET-PET in Glioblastoma (FIG) study TROG 18.06
Background: The FET-PET in Glioblastoma (FIG) study (TROG 18.06) assessed the impact of adding FET-PET to MRI on radiotherapy gross tumor volume delineation in newly diagnosed glioblastoma. Methods: This multicenter prospective phase 2 study evaluated participants with newly diagnosed glioblastoma IDH-wildtype undergoing postoperative MRI and FET-PET imaging before adjuvant radiotherapy, delivered according to standard MRI-based planning. The FET-PET-positive biological tumor volume (BTV) was used to derive the Hybrid (FET-PET+MRI) gross tumor volume (Hybrid-GTV). Primary outcomes were: (1) BTV excluded from the GTV defined on MRI alone (MR-GTV); (2) Hybrid-GTV excluded from the MR-GTV with both comparisons analyzed by non-overlap volume (cm3 and %), dosimetry (D98 and V95), and spatial similarity metrics; (3) clinically meaningful change in GTV non-overlap percentage volume with the addition of FET-PET. Results: There were 172 participants recruited, n = 140 evaluable. Median BTV was 23.1 cm3, median MR-GTV was 32.1 cm3, and median Hybrid-GTV was 46.0 cm3. Hybrid-GTV was significantly larger than the MR-GTV (P < .001), with a larger Hybrid-GTV observed in 83% of cases. Comparing BTV to MR-GTV, median non-overlap volume was 10.1 cm3 and non-overlap percentage volume 53.5%. Comparing Hybrid-GTV to MR-GTV, median non-overlap volume was 14.9 cm3 and non-overlap percentage volume 33.9%. D98 and V95 were lower for the Hybrid-GTV than for the MR-GTV, suggesting lower dose coverage. Applying a > 20% non-overlap percentage volume threshold, 76% of participants had a meaningful change in GTV with the addition of FET-PET. Conclusion: FET-PET differed significantly from MRI-based GTV delineation, with its incorporation leading to a clinically meaningful change in GTV in the majority of participants.
- 24 September 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
Open AccessImpact of [18F]FET-PET on MRI-based radiotherapy target volumes in newly diagnosed Glioblastoma: Results from the FET-PET in Glioblastoma (FIG) study TROG 18.06
Background: The FET-PET in Glioblastoma (FIG) study (TROG 18.06) assessed the impact of adding FET-PET to MRI on radiotherapy gross tumor volume delineation in newly diagnosed glioblastoma. Methods: This multicenter prospective phase 2 study evaluated participants with newly diagnosed glioblastoma IDH-wildtype undergoing postoperative MRI and FET-PET imaging before adjuvant radiotherapy, delivered according to standard MRI-based planning. The FET-PET-positive biological tumor volume (BTV) was used to derive the Hybrid (FET-PET+MRI) gross tumor volume (Hybrid-GTV). Primary outcomes were: (1) BTV excluded from the GTV defined on MRI alone (MR-GTV); (2) Hybrid-GTV excluded from the MR-GTV with both comparisons analyzed by non-overlap volume (cm3 and %), dosimetry (D98 and V95), and spatial similarity metrics; (3) clinically meaningful change in GTV non-overlap percentage volume with the addition of FET-PET. Results: There were 172 participants recruited, n = 140 evaluable. Median BTV was 23.1 cm3, median MR-GTV was 32.1 cm3, and median Hybrid-GTV was 46.0 cm3. Hybrid-GTV was significantly larger than the MR-GTV (P < .001), with a larger Hybrid-GTV observed in 83% of cases. Comparing BTV to MR-GTV, median non-overlap volume was 10.1 cm3 and non-overlap percentage volume 53.5%. Comparing Hybrid-GTV to MR-GTV, median non-overlap volume was 14.9 cm3 and non-overlap percentage volume 33.9%. D98 and V95 were lower for the Hybrid-GTV than for the MR-GTV, suggesting lower dose coverage. Applying a > 20% non-overlap percentage volume threshold, 76% of participants had a meaningful change in GTV with the addition of FET-PET. Conclusion: FET-PET differed significantly from MRI-based GTV delineation, with its incorporation leading to a clinically meaningful change in GTV in the majority of participants.
- 22 December 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (3) , 10-11
Factors associated with delay to carotid endarterectomy for acute ischaemic stroke in South Australia: A multicentre retrospective cohort study
- 22 December 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (3) , 10-11
Factors associated with delay to carotid endarterectomy for acute ischaemic stroke in South Australia: A multicentre retrospective cohort study
- 19 November 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (11) , e244440
Primary leptomeningeal low-grade Schwann cell neoplasm
We discuss an extremely rare case of low-grade Schwann cell leptomeningeal neoplasm with no evident intradural primary, presenting with rapid neurological decline leading to death reflecting the aggressive biological behaviour of this entity despite its low-grade morphology. Notwithstanding extensive investigations, the diagnosis was only established on autopsy as clinical presentation is non-specific making diagnosis challenging. This condition could be considered in patients presenting with leptomeningeal disease if initial workup of more common causes is non-revealing.
- 19 November 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (11) , e244440
Primary leptomeningeal low-grade Schwann cell neoplasm
We discuss an extremely rare case of low-grade Schwann cell leptomeningeal neoplasm with no evident intradural primary, presenting with rapid neurological decline leading to death reflecting the aggressive biological behaviour of this entity despite its low-grade morphology. Notwithstanding extensive investigations, the diagnosis was only established on autopsy as clinical presentation is non-specific making diagnosis challenging. This condition could be considered in patients presenting with leptomeningeal disease if initial workup of more common causes is non-revealing.
- 1 April 2017
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 305, 16-18
Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy
- 1 April 2017
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 305, 16-18
Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy